Search

everythinglearnresearchcommunity

for

Search:↓

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Caregivers of chronic skin disease patients face significant burdens that harm their quality of life.

Significant, lasting hair regrowth is needed to improve how patients with Alopecia Areata feel about their condition.

An integrated approach involving dermatologists, psychiatrists, and psychologists is crucial for managing skin disorders linked to psychological factors.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

Plica neuropathica can be a sign of schizophrenia and improves with antipsychotic treatment.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

Hand and forearm transplants can be successful long-term, but they come with challenges like rejection and side effects from immunosuppression.

Combining mood stabilizers with antipsychotics is more effective for treating children with bipolar disorder than using mood stabilizers alone.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Disease-specific tools better assess alopecia areata's impact on quality of life.

Young adults who had liver disease as children often experience significant health problems and frequently need transplants.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Trichotillomania is a chronic condition where people uncontrollably pull out their hair, often starting in childhood.

The conclusion is that creating natural-looking hair restoration requires replicating natural scalp whorl patterns and inserting grafts at specific angles.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Craig Ziering created a system to classify scalp hair patterns, important for improving hair restoration surgery results.

Finasteride and dutasteride may cause depression and anxiety, especially in younger men.

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

Different drugs are linked to specific mental health issues.

Anti-Ro exposed children had more reported neuro-psychiatric issues, but differences from healthy controls were not significant.

Severe hair loss in women increases the risk of mental health issues, especially social anxiety.

Extracellular vesicles could offer precise treatments for psychiatric conditions by targeting brain networks.

Exosome treatment safely increases hair density in male patients with androgenetic alopecia.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Photobiomodulation may improve certain health conditions, but more high-quality research is needed.